Choroidal Neovascularization Accompanied by Tractional Posterior Hyaloid Membrane Secondary to Candida Chorioretinitis

JaeWook Jung¹, YuCheol Kim^1, and Kwang Soo Kim¹

¹Department of Ophthalmology, Keimyung University School of Medicine, Dongsan Medical Center, Daegu, Republic of Korea

Cite this paper

JaeWook Jung, YuCheol Kim and Kwang Soo Kim. Choroidal Neovascularization Accompanied by Tractional Posterior Hyaloid Membrane Secondary to Candida Chorioretinitis. American Journal of Medical Case Reports. 2015; 3(6):167-169. doi: 10.12691/AJMCR-3-6-5

Abstract

A 62-year-old-male presented at our clinic with decreased vision and metamorphopsia(OD) for several days. He had received an anti-fungal treatment two months before for the treatment of endogenous candida choroiditis (OU). Fluorescein angiography and optical coherence tomography revealed subfoveal, juxtafoveal choroidal neovascularization and tractionalposterior hyaloidmembrane (OD). Pars planavitrectomy and epiretinal membrane removal was done, and twointravitrealbevacizumabinjections were administered. His visual symptoms were not improved and chorioretinal scar and fibrotic change were detected at fovea.

Keywords

candida retinitis, choroidal neovascularization, epiretinal membrane

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Parke DW, 2nd, Jones DB, Gentry LO. Endogenous endophthalmitis among patients with candidemia. Ophthalmology. 1982; 89(7): 789-796.
[2]	Donahue SP, Greven CM, Zuravleff JJ, et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology. 1994; 101(7): 1302-1309.
[3]	Beebe WE, Kirkland C, Price J. A subretinal neovascular membrane as a complication of endogenous Candida endophthalmitis. Ann Ophthalmol. 1987; 19(6): 207-209.
[4]	Stern GA, Fetkenhour CL, O'Grady RB. Intravitreal amphotericin B treatment of Candida endophthamitis. Arch Ophthalmol. 1977; 95(1): 89-93.
[5]	Gilbert CM, Novak MA. Successful treatment of postoperative Candida endophthalmitis in an eye with an intraocular lens implant. Am J Ophthalmol. 1984; 97(5): 593-595.
[6]	Jampol LM, Sung J, Walker JD, et al. Choroidal neovascularization secondary to Candida albicans chorioretinitis. Am J Ophthalmol. 1996;121(6):643-649.
[7]	McDonald HR, De Bustros S, Sipperley JO. Vitrectomy for epiretinal membrane with Candida chorioretinitis. Ophthalmology. 1990;97(4): 466-469.
[8]	Naoi N, Sawada A. Effect of vitrectomy on epiretinal membranes after endogenous fungal endophthalmitis. Jpn J Ophthalmol. 1996; 40(3): 434-438.
[9]	Tedeschi M, Varano M, Schiano Lomoriello D, Scassa C, Parisi V. Photodynamic therapy outcomes in a case of macular choroidal neovascularization secondary to Candida endophthalmitis. Eur J Ophthalmol. 2007; 17(1): 124-127.
[10]	Sheu SJ. Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to endogenous endophthalmitis. Kaohsiung J Med Sci. 2009; 25(11): 617-621.
[11]	Lee SH, Lee JW, Shin YU, Lee BR. Intravitreal bevacizumab injection for the treatment of choroidal neovascularization secondary to candida chorioretinitis. J Korean Ophthalmol Soc. 2014; 55(7): 1106-1110.
[12]	Lee SJ, Koh HJ. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration. Ophthalmology. 2011; 118(1): 101-110.